RxDoctor Payments Data

Lydia Biehr

Family · Milwaukee, WINPI 1023542933

Payments from drug & device makers

$666in general payments, 2019–2025

Across 31 payments — averaging $21.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$144
  • AstraZeneca$89
  • AbbVie$72
  • Exact Sciences$39
  • Alkermes, Inc.$39
  • Medtronic$36
  • plus $247 from 11 others

What the payments were for

  • Food & beverage$666100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$666 in reported general payments places this provider in the 75th percentile of 1,273 family providers in Wisconsin.

See all family providers in Wisconsin

Medicare billing

Part B allowed, 2024
$3,204
Medicare patients
14
Services billed
47

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$18,899
VraylarCariprazine Hcl13$18,514
TrulicityDulaglutide19$18,378
JanuviaSitagliptin Phosphate14$14,142
JardianceEmpagliflozin11$8,836
Humalog Kwikpen U-100Insulin Lispro13$4,752
Insulin Lispro Kwikpen U-100Insulin Lispro15$2,541
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$2,536
Albuterol Sulfate HfaAlbuterol Sulfate80$2,039
Lidocaine24$1,877
Omega-3 Acid Ethyl Esters21$1,712
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen50$1,070
Nano 2nd Gen Pen NeedlePen Needle, Diabetic12$1,062
Omeprazole50$778
Gabapentin65$768

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$20$18,89928 claims
AbbVieVraylar$72$18,51413 claims
Lilly USA, LLCTrulicity$33$18,37819 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,273 family providers in Wisconsin.

Other family in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →